Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2014-02-26 Capital/Financing Update
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
708A Institutional placement on-sale cleansing notice 1
Capital/Financing Update Classification · 95% confidence The document is a media announcement from Invion Limited dated 27 February 2014. It details the issuance of 66,666,671 fully paid ordinary shares to institutional and sophisticated investors at a specified price. The announcement references compliance with sections of the Corporations Act related to issuing shares without disclosure. The content focuses on the issuance of shares and the legal compliance notice under section 708A of the Corporations Act. There is no financial report, earnings data, or management discussion. The document is an update on capital raising activity and share issuance, fitting the category of Capital/Financing Update rather than a full financial report or regulatory filing. The document length is short and it is a direct announcement of a financing event, not a report publication or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2014-02-26 English
Invion Corporate Presentation Feb 14 27 pages 1.4MB
Investor Presentation Classification · 95% confidence The document is a detailed corporate presentation from Invion Limited dated February 2014. It includes extensive information about the company's drug candidates, clinical trial phases, management team, collaborations, market opportunities, and regulatory status of trials. The content is structured as a presentation aimed at investors or stakeholders, focusing on the company's strategy, pipeline, and clinical development progress. There are no financial statements, audit opinions, or regulatory certifications present. The document is not an earnings release or a formal regulatory filing but rather a comprehensive investor presentation. Therefore, the most appropriate classification is Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2014-02-25 English
Entitlement offer cleansing notice 1 page 238.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX media announcement dated 26 February 2014 regarding an entitlement offer by Invion Limited. It discusses the terms of a 1 for 20 non-renounceable entitlement offer to raise approximately AU$2 million, referencing the Corporations Act and ASIC Class Order. The document does not contain financial statements or detailed financial analysis but rather provides information about the capital raising event and legal compliance notices related to the offer. It is not a full financial report, earnings release, or management discussion. The document is relatively short (3618 characters) and serves as an announcement of a capital raising activity. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2014-02-25 English
Invion announces Rights Issue Entitlement Offer 2 pages 252.0KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 26 February 2014 from Invion Limited regarding a rights issue (entitlement offer) to raise approximately $2 million, subsequent to a $5 million placement. It details the terms of the entitlement offer, key dates, and the use of funds. The content focuses on fundraising activities, share issuance, and capital raising. There are no financial statements or detailed financial performance data included, only information about the capital raising event. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or other categories.
2014-02-25 English
Rights Issue Information Booklet 42 pages 2.1MB
Capital/Financing Update Classification · 100% confidence The document is titled 'Information Booklet' and details a 1 for 20 pro rata non-renounceable Entitlement Offer at 7.5 cents per share to raise approximately $2 million. It includes detailed information about the offer, legal notices, risk factors, and instructions for shareholders on how to participate. It also references a recent placement and the use of funds from the equity raising. The document is clearly an offering document related to a capital raising event, not a financial report, earnings release, or management discussion. It is not a proxy, AGM material, or voting results announcement. The content focuses on the terms and conditions of the entitlement offer and instructions for shareholders, which fits the definition of a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full booklet, not just an announcement of a report. Therefore, the correct classification is Capital/Financing Update (CAP).
2014-02-25 English
Appendix 3B Rights Issue Entitlement Offer 12 pages 501.2KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements related to these issues. The text includes detailed information about the class and number of securities issued, issue price, purpose of the issue, shareholder approvals, and quotation agreements. It also contains calculations related to placement capacity under ASX Listing Rules 7.1 and 7.1A. The document is not a financial report, earnings release, or management discussion but rather a formal announcement of a capital raising event and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the announcement itself, not just a brief notice or report publication announcement. Hence, the classification is CAP with high confidence.
2014-02-25 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.